Annotation of rs7668258
Genotype TT is associated with increased concentrations of valproic acid in people with Epilepsy as compared to genotype CC.
4 studies evaluated the association between CC & TT and adj. serum concentration of VPA. In overall analysis of 4 studies found no association with genotype and adj. serum concentration (P = 0.35). In subgroup analysis, the TT genotype was not significantly associated with serum concentration versus CC genotype in monotherapy (P =0.71) but was associated with increased concentrations based on combination therapy data (P = 0.002). No sub-group anayses were done by age.
From Publication
Gene
Variant
Phenotype Category
Association Significance
Specialty Population
PharmGKB ID
Score More info on scoring
Evidence for Clinical Annotations
This annotation has been used as evidence for the following clinical annotations.
Study Parameters
1.
Study type
Study size
Association p-value
Biogeographical group More info on groups
Population description
Drug: VPA dose adj. concentration; 2 sub-group study in patients on VPA combined therapy
2.
Study type
Study size
Association p-value
Biogeographical group More info on groups
Population description
Drug: VPA dose adj. concentration; 2 studies in patients on VPA monotherapy sub-study
3.
Study type
Study size
Association p-value
Biogeographical group More info on groups
Population description
Drug: VPA dose adj. concentration overall; 4 studies in patients on VPA
Note: Alleles in PharmGKB are mapped to the positive chromosomal strand. Therefore, variants in genes on the "minus" strand (eg. VKORC1) are complemented in PharmGKB annotations.